Effects of argatroban on thrombin-induced events in cultured vascular smooth muscle cells.
Hijikata-Okunomiya
A
A
Faculty of Health Science, Kobe University School of Medicine, Japan. okunomiy@ams.kobe-u.ac.jp
Nakaya
Y
Y
Inoue
N
N
Takahashi
A
A
Taniguchi
T
T
Wanaka
K
K
Tsuda
Y
Y
Okada
Y
Y
Ishikawa
Y
Y
D000818:Animals; D000991:Antithrombins / Q000494:pharmacology*; D001120:Arginine / Q000031:analogs & derivatives; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D004247:DNA / Q000096:biosynthesis / Q000187:drug effects; D004789:Enzyme Activation; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000378:metabolism; D010875:Pipecolic Acids / Q000494:pharmacology*; D051381:Rats; D013449:Sulfonamides; D013917:Thrombin / Q000037:antagonists & inhibitors* / Q000378:metabolism
D000991:Antithrombins; D010875:Pipecolic Acids; D013449:Sulfonamides; D004247:DNA; D001120:Arginine; D013917:Thrombin; D020778:Matrix Metalloproteinase 2; C031942:argatroban; D002118:Calcium